New Zealand

Home / Species & Products / Dogs / Cytopoint

Cytopoint

CYTOPOINT is a new therapy that targets atopic itch at its source. Each injection lasts one month. 

 

Expand All
  • Key Features

    Cytopoint provides fast, effective relief that helps improve the long-term quality of life for dogs with atopic dermatitis and their families.

    1 Cytopoint injection helps control itch for 1 month

     

    TARGETED

    Targets and neutralises interleukin (IL)-31, a key itch-inducing cytokine in atopic dermatitis.2

    WORKS FAST AND LASTS

    Begins working within 1 day and delivers one month of relief from clinical signs of atopic dermatitis; in-clinic administration ensures compliance.1

    SAFER

    Safer for dogs of all ages, even those with concomitant diseases, and can be used with many common medications3,4

  • Packaging

    Lokivetmab is a clear solution for injection, available in single-dose 1mL vials containing 10mg, 20mg, 30mg and 40mg lokivetmab.

     

  • Dosage & Administration

    The recommended minimum dose is 1mg/kg bodyweight, administered subcutaneously, once a month.  In cases of atopic dermatitis, investigate and treat complicating factors, such as bacterial, fungal or parasitic infections/infestations. 

      

  • Precautions

    Lokivetmab may induce transient or persistent anti-drug antibodies. The induction of such antibodies may have an effect on the efficacy of lokivetmab. As with any immunological product, in rare cases, hypersensitivity reactions may occur. If such a reaction occurs, administer appropriate symptomatic treatment without delay.  

    No drug interactions were observed in field studies where lokivetmab was administered concomitantly with other veterinary medicines such as endo- and ectoparasiticides, antimicrobials, anti-inflammatories and vaccines.

    Do not use in case of hypersensitivity to active substance or any of the excipients. Do not use in dogs weighing less than 3kg. The safety of Cytopoint has not been established during pregnancy and lactation. Therefore, it is not recommended during pregnancy or lactation, or in dogs intended for breeding. 

    Hypersensitivity, including anaphylaxis, could potentially occur in the case of accidental self-injection. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or label to the physician.

    Store at 2-8°C. Refrigerate. Do not freeze. Protect from light. Avoid excessive shaking.

  • Mandatories

    Zoetis New Zealand Limited. Tel: 0800 963 847; www.zoetis.co.nz. CYTOPOINT is a registered trade mark of Zoetis. ACVM No.’s A11348, A11443, A11444 and A11445. RVM; Available only under Veterinary Authorisation

  • Contact Information

    For technical enquiries please phone Zoetis Technical Services on 0800 650 277.